Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients.
about
Minimal residual disease in breast cancer: an overview of circulating and disseminated tumour cellsCirculating tumors cells as biomarkers: progress toward biomarker qualificationPancreatic cancer: Are "liquid biopsies" ready for prime-time?Circulating Tumor Cells Versus Circulating Tumor DNA in Colorectal Cancer: Pros and Cons.Prostate cancer invasion and metastasis: insights from mining genomic data.Circulating tumor cells in melanoma patientsModeling platinum sensitive and resistant high-grade serous ovarian cancer: development and applications of experimental systems.Rationale and preclinical efficacy of a novel anti-EMP2 antibody for the treatment of invasive breast cancer.Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancerMolecular detection of peripheral blood breast cancer mRNA transcripts as a surrogate biomarker for circulating tumor cellsCGB and GNRH1 expression analysis as a method of tumor cells metastatic spread detection in patients with gynecological malignances.Identification of novel molecular markers for detection of gastric cancer cells in the peripheral blood circulation using genome-wide microarray analysisSingle cell analysis of cancer cells using an improved RT-MLPA method has potential for cancer diagnosis and monitoring.Gene expression profiling of circulating tumor cells and peripheral blood mononuclear cells from breast cancer patients.The potential for liquid biopsies in the precision medical treatment of breast cancer.Detection of disseminated tumor cells in the bone marrow of breast cancer patients using multiplex gene expression measurements identifies new therapeutic targets in patients at high risk for the development of metastatic diseaseReview of the GAS3 Family of Proteins and their Relevance to Cancer.Isolation of rare circulating tumor cells in cancer patients: technical aspects and clinical implications.Tumor-associated circulating microRNAs as biomarkers of cancer.Circulating tumor cells as promising novel biomarkers in solid cancers.Circulating tumor cells as trigger to hematogenous spreads and potential biomarkers to predict the prognosis in ovarian cancer.Gene expression profiling and DNA methylation analyses of CTCs.Circulating tumor cell technologies.Circulating cell-free DNA and circulating tumor cells, the "liquid biopsies" in ovarian cancer.Cytokeratin-19 and mammaglobin gene expression in circulating tumor cells from metastatic breast cancer patients enrolled in North Central Cancer Treatment Group trials, N0234/336/436/437.Efficient leukocyte depletion by a novel microfluidic platform enables the molecular detection and characterization of circulating tumor cells.Emerging diagnostic, prognostic and therapeutic biomarkers for ovarian cancer.Review article: Novel technologies in the treatment and monitoring of advanced and relapsed epithelial ovarian cancer.Liquid Biopsy in Endometrial Cancer: New Opportunities for Personalized Oncology
P2860
Q26748850-A084B5E6-E73A-43DF-911D-3C38638FC743Q26852579-D7446FA7-880E-4415-8EDE-A5A605551013Q28068665-6D9D3CC1-8D9D-48E0-B21A-BC78EA973AE9Q30355079-CE1146C0-4284-4D1C-B654-B7EA107AE73EQ30656758-34073067-4B55-4F99-AC5E-EDBC244C872CQ31075758-3BEAB205-B891-4B6D-A047-9D92FCD8B052Q33641924-6D77E7D1-B9D2-4399-BE88-14AB3514F2ECQ33668653-82AF5D46-A5C1-4DDA-9C72-5024BFCEF62AQ34310001-BADC1319-9223-4A18-8D6A-E36C7FD30749Q34994514-F9EB8EC1-76F3-4347-94CC-13367727B496Q35213724-7EAA4552-6873-4CFA-B6F6-D45CC5AB6AF5Q36230729-BC1C96E7-6A6D-4C8A-BEE6-1E3EC40FA43EQ36272624-D5435918-58C7-4960-B96F-A52666F5AF33Q36821154-B964CB8D-D416-454B-B689-68D4F0AB4255Q36849660-7D021CD5-1419-4960-A5D9-EC4657E86328Q37036125-1DAA6E33-99FE-4896-A482-E06587D4BFF5Q37716267-FEACA4E2-29A4-4FDF-9FD0-B5BC9D0120BAQ37894736-B055700D-3890-45EF-BC91-36E296FAFE5DQ38187323-F7B99611-4BCB-4AEA-8911-A26AD76E1884Q38196920-CE59B36E-79BD-456D-87C4-1BE2AEF663D0Q38616195-660E5AF6-5727-47DC-B66F-CE95B06956FEQ38734877-D473BADB-8944-41DA-B643-FE142C66CACCQ38742272-8E6BBDC4-AAC5-4204-A40A-EAEAEF76AB2EQ47094357-D2905F45-8A8F-4D36-B455-F99851255CC2Q47109459-CBDB3C60-429C-4ACC-9069-E2D104A85B80Q50065802-38680193-E406-4121-8050-844669102DE5Q52941950-7C8F0622-A97A-4635-842D-69E2312BF323Q53602004-6E14DE7B-6C71-48B4-97B1-00055C64C475Q58796795-192D737F-E8A8-4114-BFF6-294DB5C14EF1
P2860
Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Assessment of a six gene panel ...... ood of female cancer patients.
@ast
Assessment of a six gene panel ...... ood of female cancer patients.
@en
type
label
Assessment of a six gene panel ...... ood of female cancer patients.
@ast
Assessment of a six gene panel ...... ood of female cancer patients.
@en
prefLabel
Assessment of a six gene panel ...... ood of female cancer patients.
@ast
Assessment of a six gene panel ...... ood of female cancer patients.
@en
P2093
P2860
P50
P356
P1433
P1476
Assessment of a six gene panel ...... lood of female cancer patients
@en
P2093
Alexander Reinthaller
Christian F Singer
Jalid Sehouli
Michael B Fischer
Muy-Kheng M Tea
Reinhard Horvat
P2860
P2888
P356
10.1186/1471-2407-10-666
P407
P577
2010-12-03T00:00:00Z
P5875
P6179
1018781777